Cancers of the skin and kidney that have spread throughout the body are typically resistant to drug treatment, so researchers have turned to a compound called IL-2 to boost the body’s immune response against these tumors. However, IL-2 can cause life-threatening low blood pressure.
To counter that side effect, researchers are looking toward M40403, a synthetic enzyme.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.